Fasson technology | AstraZeneca vaccine may be associated with cerebral thrombosis, but the overall benefits outweigh the risks
Time：
On Wednesday, the European Union's drug regulator (EMA) said the new AstraZeneca crown vaccine may be associated with a rare cerebral thrombosis, while reiterating that the overall benefits outweigh the risks.
